Correlation Between Verona Pharma and Crinetics Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Verona Pharma and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verona Pharma and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Verona Pharma PLC and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Verona Pharma and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verona Pharma with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verona Pharma and Crinetics Pharmaceuticals.

Diversification Opportunities for Verona Pharma and Crinetics Pharmaceuticals

0.77

Correlation Coefficient

Verona Pharma  Crinetics Pharmaceuticals

Poor diversification

The 3 months correlation between Verona and Crinetics is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Verona Pharma PLC and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Verona Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verona Pharma PLC are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Verona Pharma i.e., Verona Pharma and Crinetics Pharmaceuticals go up and down completely randomly.

Pair Corralation between Verona Pharma and Crinetics Pharmaceuticals

Given the investment horizon of 90 days Verona Pharma PLC is expected to generate 1.18 times more return on investment than Crinetics Pharmaceuticals. However, Verona Pharma is 1.18 times more volatile than Crinetics Pharmaceuticals. It trades about 0.17 of its potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about 0.09 per unit of risk. If you would invest  2,999  in Verona Pharma PLC on September 12, 2024 and sell it today you would earn a total of  946.00  from holding Verona Pharma PLC or generate 31.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Verona Pharma PLC  vs.  Crinetics Pharmaceuticals

Verona Pharma PLC

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Verona Pharma PLC are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Verona Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Crinetics Pharmaceuticals

Risk-Adjusted Performance

6 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Crinetics Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Crinetics Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Verona Pharma and Crinetics Pharmaceuticals

The main advantage of trading using opposite Verona Pharma and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verona Pharma position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.

The idea behind Verona Pharma PLC and Crinetics Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.